Tumor markers and drug targeting

Tumor markers are substances that are produced by cancer or by other cells of the body in response to cancer or certain benign (noncancerous) conditions. Most tumor markers are made by normal cells as well as by cancer cells; however, they are produced at much higher levels in cancerous conditions. These substances can be found in the blood, urine, stool, tumor tissue, or other tissues or bodily fluids of some patients with cancer. Most tumor markers are proteins. Thus far, more than 20 different tumor markers have been characterized and are in clinical use. Some are associated with only one type of cancer, whereas others are associated with two or more cancer types. There is no “universal” tumor marker that can detect any type of cancer. Among various approaches to specifically target drug-loaded carrier systems to required pathological sites in the body, two seem to be most advanced – passive (EPR effect-mediated) targeting, based on the longevity of the pharmaceutical carrier in the blood and its accumulation in pathological sites with compromised vasculature, and active targeting, based on the attachment of specific ligands to the surface of pharmaceutical carriers to recognize and bind pathological cells. 

  • Cytotoxic drugs
  • Chemotherapy drugs
  • Tyrosine kinase inhibitors

Related Conference of Tumor markers and drug targeting

June 29-July 01, 2017

8th European Immunology Conference

Madrid, Spain
July 03-04, 2017

9th Annual Meeting on Immunology and Immunologist

Kuala Lumpur, Malaysia
July 12-13, 2017

3rd World Conference on Parasitology & Pathogenesis

Chicago, Illinois, USA
September 01-02, 2017

4th International Conference on Parasitology

Prague, Czech Republic
September 14-15, 2017

7th World Congress on Immunology

Amsterdam, Netherlands
September 21-22, 2017

International Conference on Parasitology and Infectious Diseases

San Antonio, Texas, USA
November 01-03, 2017

Vaccines-2017 (CME & CPD Accredited)

Valencia, Spain
November 06-08, 2017

Infectious-diseases- 2017 (CME & CPD Accredited)

Valencia, Spain
November 2-3, 2017

9th World Congress and Expo on Immunology

Atlanta, Georgia, USA
November 02-03, 2017

9th World Congress on Immunity, Inflammation and Immunotherapies

Atlanta, Georgia, USA
November 06-07, 2017

2nd International Conference on Autoimmunity

Frankfurt, Germany
November 06 - 07, 2017

Immunology-2017

Frankfurt, Germany
November 08-09, 2017

3rd Antibodies and Bio Therapeutics Congress

Las Vegas, Nevada, USA
November 13-14, 2017

5th International Conference on HIV/AIDS, STDs and STIs

Las Vegas, Nevada, USA
December 04-06, 2017

Oncology- 2017 (CME & CPD Accredited)

London, UK
Dec 14-15, 2017

World Immunology Congress

Dubai, UAE

Tumor markers and drug targeting Conference Speakers

Recommended Sessions

Related Journals

Are you interested in